Regarding pharmacological treatment, for several decades it has been well documented that RAAS blockers, particularly in the presence of albuminuria or proteinuria, should be administered to reduce not only arterial hypertension and the increased activation of the system but also sympathetic overactivity, insulin resistance, and low-grade inflammation, with the indication of close control of renal function indices (42). Here, INS is linked to Hypertension.